Tierarztl Prax Ausg K Kleintiere Heimtiere 2019; 47(03): 210
DOI: 10.1055/s-0039-1688611
Vorträge
Klein- und Heimtiere
Georg Thieme Verlag KG Stuttgart · New York

The transcriptional program of feline injection-site sarcoma

CV Löhr
1   Carlson College of Veterinary Medicine, Oregon State University, Corvallis, USA
,
Q Wei
1   Carlson College of Veterinary Medicine, Oregon State University, Corvallis, USA
,
MK Larson
1   Carlson College of Veterinary Medicine, Oregon State University, Corvallis, USA
,
C Shiprack
1   Carlson College of Veterinary Medicine, Oregon State University, Corvallis, USA
,
SA Ramsey
1   Carlson College of Veterinary Medicine, Oregon State University, Corvallis, USA
› Author Affiliations
Further Information

Publication History

Publication Date:
18 June 2019 (online)

 

Background:

Soft tissue sarcomas are common skin tumors in cats. Feline injection-site associated sarcoma (FISS) is an aggressive subtype that develops at sites of previous injection and whose pathogenesis is poorly understood.

Materials and Methods:

FISS vs. normal tissue were comparatively profiled by high-throughput short-read paired-end sequencing, for cancer/normal gene expression levels followed by post-hoc analyses.

Results:

Our research found transcriptional alterations in FISS vs. normal tissue and identified large overlap between human orthologs of cat genes with altered transcriptional abundances in FISS and known human tumor suppressor genes and oncogenes. A 10 Mbp region of potential somatic copy number alteration (SCNA) in FISS is syntenic to a human genomic region with recurrent SCNA in human sarcomas. Our results closely align with findings in human and canine sarcomas.

Conclusions:

To the best of our knowledge, this is the first mRNA sequencing-based transcriptome profiling study of FISS and any cancer in cats.